Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-090514
Filing Date
2025-09-16
Accepted
2025-09-16 19:00:59
Documents
1
Period of Report
2025-09-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2526247-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2526247-1_4seq1.xml 4 9909
  Complete submission text file 0001104659-25-090514.txt   11348
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address
Yocca Frank (Reporting) CIK: 0001733272 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 251318418